We convene the brightest minds in oncology, healthcare, pharma, and policy to challenge the status quo.

We bring oncologists, health system leaders, payers, pharmaceutical executives, policy makers, and patient advocates into sustained dialogue about the challenges no single stakeholder can solve alone: reducing treatment variation, aligning incentives, improving access, and translating research breakthroughs into clinical practice. Because where leaders lead, markets follow.